Literature DB >> 17992360

Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS).

Jussara Mendonça Alvarenga1, Antônio Ignácio de Loyola Filho, Josélia Oliveira Araújo Firmo, Maria Fernanda Lima-Costa, Elizabeth Uchoa.   

Abstract

OBJECTIVES: To assess the prevalence and sociodemographic characteristics associated with benzodiazepine use among community-dwelling older adults.
METHOD: 1606 subjects, aged > 60 years, corresponding to 92% of the residents of Bambuí city, participated in this study. The information about medication use was obtained by means of a standard interview and the review of medication packaging. Substances were classified using the Anatomical Therapeutic Chemical Index.
RESULTS: The prevalence of benzodiazepine current use was 21.7% (26.7% among females and 14.0% among males). From these, 68.7% had been taking the medication for over one year, 31.3% for over five years and 53.2% were using long half-life benzodiazepines. The medication most frequently used was bromazepam (35.6%), followed by diazepam (22.5%), clonazepam (12.6%) and lorazepam (7.8%). After adjustment for confounders, female gender (RP = 1.93; CI95% = 1.51-2.46) was the only sociodemographic characteristic found to be independently associated with substance consumption.
CONCLUSIONS: The prevalence of benzodiazepine use in the study population was high, but within the variation observed in developed countries. Chronic use of benzodiazepines and long half-life medications predominated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992360     DOI: 10.1590/s1516-44462006005000062

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  11 in total

1.  Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults.

Authors:  Mariana Martins Gonzaga do Nascimento; Juliana Vaz de Melo Mambrini; Maria Fernanda Lima-Costa; Josélia Oliveira Araújo Firmo; Sérgio William Viana Peixoto; Antônio Ignácio de Loyola Filho
Journal:  Eur J Clin Pharmacol       Date:  2017-01-20       Impact factor: 2.953

2.  Psychotropic drug use in community-dwelling elderly people-characteristics of persistent and incident users.

Authors:  Maria Rikala; Maarit Jaana Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Eur J Clin Pharmacol       Date:  2011-02-05       Impact factor: 2.953

Review 3.  A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people.

Authors:  Emily Reeve; Magdalene Ong; Angela Wu; Jesse Jansen; Mirko Petrovic; Danijela Gnjidic
Journal:  Eur J Clin Pharmacol       Date:  2017-04-30       Impact factor: 2.953

4.  Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain.

Authors:  Jorge Simal-Aguado; María-Pilar Campos-Navarro; Francisco Valdivia-Muñoz; Alejandro Galindo-Tovar; Juan Antonio García-Carmona
Journal:  Psychopharmacol Bull       Date:  2021-01-12

5.  Benzodiazepine use among adults residing in the urban settlements of Karachi, Pakistan: a cross sectional study.

Authors:  Saleem P Iqbal; Syed Ahmer; Salima Farooq; Yasmin Parpio; Ambreen Tharani; Rashid A M Khan; Mohammad Zaman
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-08-01

6.  Social differences associated with the use of psychotropic drugs among men and women aged 65 to 74 years living in the community: the International Mobility in Aging Study (IMIAS).

Authors:  Gustave Noufou Nana; Boukaré Doulougou; Fernando Gomez; Alban Ylli; Jack Guralnik; Maria Victoria Zunzunegui
Journal:  BMC Geriatr       Date:  2015-07-20       Impact factor: 3.921

7.  Chronic use of benzodiazepines among older adults.

Authors:  Jussara Mendonça Alvarenga; Karla Cristina Giacomin; Antônio Ignácio de Loyola Filho; Elizabeth Uchoa; Josélia Oliveira Araújo Firmo
Journal:  Rev Saude Publica       Date:  2014-12       Impact factor: 2.106

8.  Use of hypnotics and the risk of or mortality from heart disease: a meta-analysis of observational studies.

Authors:  Young-Hyo Kim; Hong-Bae Kim; Do-Hyoung Kim; Ja-Young Kim; Hyun-Young Shin
Journal:  Korean J Intern Med       Date:  2017-08-28       Impact factor: 2.884

9.  The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study.

Authors:  Danijela Gnjidic; Hui Min Magdalene Ong; Celeste Leung; Jesse Jansen; Emily Reeve
Journal:  Ther Adv Drug Saf       Date:  2019-01-17

10.  Association Between Benzodiazepine Use and Epilepsy Occurrence: A Nationwide Population-Based Case-Control Study.

Authors:  Tomor Harnod; Yu-Chiao Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.